Deep vein thrombosis and pulmonary embolism affect hundreds of thousands of people each year — and a significant fraction of those cases are genetically driven. The F2 G20210A variant is the second most common inherited clotting disorder after Factor V Leiden. It is present in roughly 2–3% of European-ancestry populations and raises lifetime clot risk meaningfully, especially when combined with environmental triggers.
Prothrombin (Factor II) is a clotting protein circulating in the blood. When a vessel is injured, it is converted to thrombin — the active enzyme that converts fibrinogen to fibrin, forming the structural scaffold of a blood clot. The system is tightly regulated; too little prothrombin means excessive bleeding, too much means clots form too readily.
The G20210A variant sits in the 3' untranslated region of the F2 gene and increases the efficiency of mRNA processing, resulting in approximately 30% more prothrombin in circulation. This shifts the coagulation system toward a pro-thrombotic state — not dramatically enough to cause problems most days, but meaningfully enough to increase risk when other clotting triggers are present.
Risk Multiplication: When Genetics Meets Environment
The G20210A variant on its own confers a 2–3x lifetime increase in venous thromboembolism risk — significant, but not extreme. The risk becomes clinically important when it compounds with environmental triggers:
Estrogen increases production of several clotting factors independently. Combined with G20210A, the risk of DVT increases approximately 15–16x compared to non-carrier non-users. This combination is the most common context in which young women present with their first clot.
Pregnancy
Pregnancy is a naturally hypercoagulable state. G20210A carriers have higher rates of pregnancy-related DVT and, importantly, placental thrombosis — associated with recurrent miscarriage, preeclampsia, and fetal growth restriction.
Major surgery and prolonged immobility
Immobility reduces venous return and surgery activates the coagulation cascade. Carriers undergoing major orthopedic or abdominal surgery may need extended anticoagulation prophylaxis beyond standard protocols.
Long-haul flights
Economy class syndrome is real and more dangerous for carriers. Flights over 8 hours in cramped conditions increase clot risk even in non-carriers; G20210A carriers should prioritize movement, hydration, and compression stockings.
Co-existing Factor V Leiden
Carrying both F2 G20210A and Factor V Leiden (F5 rs6025) is the highest-risk combination in inherited thrombophilia. Risk of first clot is 20x baseline. This co-occurrence is rare but clinically significant.
What to Do If You Carry G20210A
Tell your doctor before starting hormonal contraception
This is the most important immediate action. Combined oral contraceptives are relatively contraindicated in G20210A carriers. Progestin-only methods (mini-pill, Mirena, Nexplanon) do not carry the same risk and are generally safe alternatives.
Discuss anticoagulation before elective surgery
Your surgeon and anesthesiologist should know your genotype. Extended low-molecular-weight heparin prophylaxis after orthopedic surgery is often warranted for carriers.
Test first-degree relatives
G20210A is autosomal dominant. Each first-degree relative has a 50% chance of carrying the same variant. Testing siblings and children before they encounter high-risk situations (surgery, pregnancy, OCP use) is valuable.
Compression and movement on long flights
Wear graduated compression stockings (15–20 mmHg) on flights over 4 hours. Get up and walk every 1–2 hours. Stay well-hydrated. These are simple and highly effective interventions.
Prophylactic anticoagulation in pregnancy
Carriers with a prior clot history typically receive low-molecular-weight heparin throughout pregnancy and 6 weeks postpartum. Even carriers without prior clots should discuss this with their OB — the decision depends on personal and family history.
Check Your Clotting Genes
Upload your 23andMe or AncestryDNA file to see F2, Factor V Leiden, PAI-1, and 60+ other variants — analyzed privately in your browser.
Poort SR et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698–3703.
Martinelli I et al. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med. 2003;163(22):2771–2774.
Gerhardt A et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342(6):374–380.